TNDM Tandem Diabetes Care Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: TNDM

Price (delayed)

$42.11

Market cap

$2.72B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.47

Enterprise value

$2.96B

Tandem Diabetes Care is a public US medical device manufacturer based in San Diego, CA. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy. ...

Highlights
TNDM's revenue is up by 14% year-on-year
Tandem Diabetes Care's gross profit has increased by 10% YoY
Tandem Diabetes Care's quick ratio has decreased by 20% YoY but it has increased by 6% from the previous quarter
Tandem Diabetes Care's EPS has decreased by 40% from the previous quarter
The net income has decreased by 39% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: https://www.tandemdiabetes.com/
Peers: DXCM PODD ICUI DCTH

Key stats

What are the main financial stats of TNDM
Market
Shares outstanding
64.53M
Market cap
$2.72B
Enterprise value
$2.96B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.15
Price to sales (P/S)
3.37
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.7
Earnings
Revenue
$801.22M
EBIT
-$86.64M
EBITDA
-$72.31M
Free cash flow
$16.37M
Per share
EPS
-$1.47
Free cash flow per share
$0.26
Book value per share
$6.84
Revenue per share
$12.49
TBVPS
$16.41
Balance sheet
Total assets
$1.05B
Total liabilities
$612.84M
Debt
$419.88M
Equity
$439.95M
Working capital
$684.69M
Liquidity
Debt to equity
0.95
Current ratio
5.14
Quick ratio
4.43
Net debt/EBITDA
-3.42
Margins
EBITDA margin
-9%
Gross margin
51.5%
Net margin
-11.8%
Operating margin
-11.6%
Efficiency
Return on assets
-9.1%
Return on equity
-21.6%
Return on invested capital
-7.3%
Return on capital employed
-9.8%
Return on sales
-10.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TNDM stock price

How has the Tandem Diabetes Care stock price performed over time
Intraday
0.91%
1 week
2.36%
1 month
15.72%
1 year
-62.54%
YTD
-6.32%
QTD
-6.32%

Financial performance

How have Tandem Diabetes Care's revenue and profit performed over time
Revenue
$801.22M
Gross profit
$412.99M
Operating income
-$92.85M
Net income
-$94.59M
Gross margin
51.5%
Net margin
-11.8%
The operating income fell by 49% QoQ
The operating margin has contracted by 47% from the previous quarter
The net income has decreased by 39% from the previous quarter
The net margin has decreased by 37% from the previous quarter

Growth

What is Tandem Diabetes Care's growth rate over time

Valuation

What is Tandem Diabetes Care stock price valuation
P/E
N/A
P/B
6.15
P/S
3.37
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.7
Tandem Diabetes Care's EPS has decreased by 40% from the previous quarter
TNDM's price to book (P/B) is 68% less than its 5-year quarterly average of 19.3 and 37% less than its last 4 quarters average of 9.8
The company's equity rose by 4.3% QoQ
The P/S is 67% lower than the 5-year quarterly average of 10.3 and 40% lower than the last 4 quarters average of 5.6
TNDM's revenue is up by 14% year-on-year

Efficiency

How efficient is Tandem Diabetes Care business performance
Tandem Diabetes Care's ROS has decreased by 44% from the previous quarter
The return on invested capital has declined by 40% since the previous quarter
TNDM's ROE is down by 38% from the previous quarter
The return on assets has declined by 34% since the previous quarter

Dividends

What is TNDM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TNDM.

Financial health

How did Tandem Diabetes Care financials performed over time
The total assets is 72% greater than the total liabilities
The total liabilities has grown by 30% YoY but it has contracted by 2.1% from the previous quarter
Tandem Diabetes Care's quick ratio has decreased by 20% YoY but it has increased by 6% from the previous quarter
The debt is 4.6% less than the equity
The debt has increased by 33% YoY
The company's debt to equity rose by 30% YoY but it fell by 5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.